Literature DB >> 18001844

Verbal memory, negative symptomatology and prediction of psychosocial functioning in schizophrenia.

Olga Puig1, Rafael Penadés, Cristobal Gastó, Rosa Catalán, Anna Torres, Manel Salamero.   

Abstract

Negative symptomatology and neurocognitive variables have been considered good predictors of functional outcome in schizophrenia. Specifically, secondary verbal memory has been proposed to be one of the main predictors of psychosocial functioning. In this study, negative symptoms and memory performance were analyzed for associations with psychosocial function. Linear regression methods were used to analyze the value of verbal memory and negative symptomatology as predictors of everyday life skills in a sample of 29 DSM-IV schizophrenia outpatients with predominant negative symptoms. We also took into account the role of gender in the analyses. Secondary verbal memory was found to explain 40% of the variance in psychosocial functioning, independently of gender, whereas the negative symptoms predicted 26%. When both variables were combined, the explained variance was about 49%. These results support the hypothesis that cognitive variables are better predictors than symptomatology. Finally, secondary verbal memory is a good predictor of psychosocial functioning in chronic schizophrenia with predominant negative symptomatology.

Entities:  

Mesh:

Year:  2007        PMID: 18001844     DOI: 10.1016/j.psychres.2007.04.017

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  14 in total

1.  Expanding the ecological validity of WAIS-IV and WMS-IV with the Texas functional living scale.

Authors:  Lisa Whipple Drozdick; C Munro Cullum
Journal:  Assessment       Date:  2010-10-04

2.  Processing speed and executive functions predict real-world everyday living skills in adolescents with early-onset schizophrenia.

Authors:  O Puig; R Penadés; I Baeza; V Sánchez-Gistau; E De la Serna; L Fonrodona; S Andrés-Perpiñá; M Bernardo; J Castro-Fornieles
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-02-22       Impact factor: 4.785

3.  The Portuguese version of the Personal and Social Performance Scale (PSP): reliability, validity, and relationship with cognitive measures in hospitalized and community schizophrenia patients.

Authors:  Sofia Brissos; Filipa Palhavã; João Gama Marques; Susana Mexia; Ana Lisa Carmo; Manuel Carvalho; Cátia Dias; João Data Franco; Rita Mendes; Pedro Zuzarte; Ana Isabel Carita; Andrew Molodynski; Maria Luisa Figueira
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-07-08       Impact factor: 4.328

4.  The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study.

Authors:  Eric C Meyer; Ricardo E Carrión; Barbara A Cornblatt; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Robert Heinssen; Larry J Seidman
Journal:  Schizophr Bull       Date:  2014-02-18       Impact factor: 9.306

5.  Revised associative inference paradigm confirms relational memory impairment in schizophrenia.

Authors:  Kristan Armstrong; Lisa E Williams; Stephan Heckers
Journal:  Neuropsychology       Date:  2012-05-21       Impact factor: 3.295

Review 6.  Recent advances in treating cognitive impairment in schizophrenia.

Authors:  Cherrie Galletly
Journal:  Psychopharmacology (Berl)       Date:  2008-09-03       Impact factor: 4.530

7.  The association between childhood trauma and memory functioning in schizophrenia.

Authors:  Ciaran Shannon; Kate Douse; Chris McCusker; Lorraine Feeney; Suzanne Barrett; Ciaran Mulholland
Journal:  Schizophr Bull       Date:  2009-09-13       Impact factor: 9.306

Review 8.  Social interaction and social withdrawal in rodents as readouts for investigating the negative symptoms of schizophrenia.

Authors:  Christina A Wilson; James I Koenig
Journal:  Eur Neuropsychopharmacol       Date:  2013-11-26       Impact factor: 4.600

9.  The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients.

Authors:  Katja Ribbe; Heidi Friedrichs; Martin Begemann; Sabrina Grube; Sergi Papiol; Anne Kästner; Martin F Gerchen; Verena Ackermann; Asieh Tarami; Annika Treitz; Marlene Flögel; Lothar Adler; Josef B Aldenhoff; Marianne Becker-Emner; Thomas Becker; Adelheid Czernik; Matthias Dose; Here Folkerts; Roland Freese; Rolf Günther; Sabine Herpertz; Dirk Hesse; Gunther Kruse; Heinrich Kunze; Michael Franz; Frank Löhrer; Wolfgang Maier; Andreas Mielke; Rüdiger Müller-Isberner; Cornelia Oestereich; Frank-Gerald Pajonk; Thomas Pollmächer; Udo Schneider; Hans-Joachim Schwarz; Birgit Kröner-Herwig; Ursula Havemann-Reinecke; Jens Frahm; Walter Stühmer; Peter Falkai; Nils Brose; Klaus-Armin Nave; Hannelore Ehrenreich
Journal:  BMC Psychiatry       Date:  2010-11-10       Impact factor: 3.630

10.  The importance of measuring psychosocial functioning in schizophrenia.

Authors:  Sofia Brissos; Andrew Molodynski; Vasco Videira Dias; Maria Luísa Figueira
Journal:  Ann Gen Psychiatry       Date:  2011-06-24       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.